{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:55:23Z","timestamp":1791590123056,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["2022051"],"award-info":[{"award-number":["2022051"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL168188"],"award-info":[{"award-number":["R01HL168188"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL167974"],"award-info":[{"award-number":["R01HL167974"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL169345"],"award-info":[{"award-number":["R01HL169345"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajpc.2026.101672","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:15:54Z","timestamp":1778836554000},"page":"101672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High-density lipoprotein cholesterol: function, dysfunction, and clinical implications"],"prefix":"10.1016","volume":"28","author":[{"given":"Sophia","family":"Trabanino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-8565","authenticated-orcid":false,"given":"Annabelle","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajpc.2026.101672_bib0001","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"18","key":"10.1016\/j.ajpc.2026.101672_bib0002","first-page":"e359","article-title":"ACC\/AHA clinical practice guidelines core principles and development process: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"152","author":"Otto","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101672_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001457","article-title":"ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of dyslipidemia: a report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"153","author":"Blumenthal","year":"2026","journal-title":"Circulation"},{"issue":"44","key":"10.1016\/j.ajpc.2026.101672_bib0004","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1093\/eurheartj\/ehz826","article-title":"Corrigendum to: 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","year":"2020","journal-title":"Eur Heart J"},{"issue":"17","key":"10.1016\/j.ajpc.2026.101672_bib0005","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88628","article-title":"Lymphocyte activation gene 3 and coronary artery disease","volume":"1","author":"Golden","year":"2016","journal-title":"JCI Insight"},{"issue":"6278","key":"10.1016\/j.ajpc.2026.101672_bib0006","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101672_bib0007","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the american heart association\u2019s PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ajpc.2026.101672_bib0008","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.120.044221","article-title":"HDL in the 21st century: a multifunctional roadmap for future HDL research","volume":"143","author":"Rohatgi","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101672_bib0009","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehac605","article-title":"High-density lipoprotein revisited: biological functions and clinical relevance","volume":"44","author":"von Eckardstein","year":"2023","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101672_bib0010","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpc.2026.101672_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2022.960522","article-title":"Clinical relevance of nuclear magnetic resonance LipoProfile","volume":"2","author":"Emeasoba","year":"2022","journal-title":"Front Nucl Med"},{"key":"10.1016\/j.ajpc.2026.101672_bib0012","series-title":"Endotext [Internet]","article-title":"Effect of inflammation and infection on lipids and lipoproteins","author":"Feingold","year":"2000"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101672_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094585","article-title":"Effect of HDL-raising drugs on cardiovascular outcomes: a systematic review and meta-regression. Bursill C, editor","volume":"9","author":"Kaur","year":"2014","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101672_bib0014","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1161\/01.ATV.0000104029.74961.f5","article-title":"Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I","volume":"24","author":"Rye","year":"2004","journal-title":"ATVB"},{"issue":"5248","key":"10.1016\/j.ajpc.2026.101672_bib0015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1126\/science.271.5248.518","article-title":"Identification of scavenger receptor SR-BI as a high density lipoprotein receptor","volume":"271","author":"Acton","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101672_bib0016","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1093\/cvr\/cvu150","article-title":"HDL in innate and adaptive immunity","volume":"103","author":"Catapano","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101672_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","article-title":"The plasma lecithin:cholesterol acyltransferase reaction","volume":"9","author":"Glomset","year":"1968","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpc.2026.101672_bib0018","series-title":"Drugs affecting lipid metabolism [Internet]","first-page":"42","article-title":"Transport of cholesterol and cholesterol esters by HDL","author":"Steinberg","year":"1987"},{"key":"10.1016\/j.ajpc.2026.101672_bib0019","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1146\/annurev-nutr-071811-150709","article-title":"New roles of HDL in inflammation and hematopoiesis","volume":"32","author":"Zhu","year":"2012","journal-title":"Annu Rev Nutr"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101672_bib0020","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1161\/ATVBAHA.124.321001","article-title":"COVID-19 is a coronary artery disease risk equivalent and exhibits a genetic interaction with ABO blood type","volume":"44","author":"Hilser","year":"2024","journal-title":"Arter Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101672_bib0021","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2014-09-599530","article-title":"High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion","volume":"127","author":"Chung","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101672_bib0022","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s42003-022-03304-0","article-title":"Lymphocyte activation gene-3-associated protein networks are associated with HDL-cholesterol and mortality in the Trans-omics for Precision Medicine program","volume":"5","author":"Manichaikul","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.ajpc.2026.101672_bib0023","article-title":"Soluble immune checkpoint protein and lipid network associations with all-cause mortality risk: trans-omics for Precision medicine (TOPMed) program","author":"Rodriguez","year":"2025","journal-title":"medRxiv"},{"issue":"22","key":"10.1016\/j.ajpc.2026.101672_bib0024","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.jacc.2022.09.027","article-title":"Race-dependent association of high-density lipoprotein cholesterol levels with incident coronary artery disease","volume":"80","author":"Zakai","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101672_bib0025","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/j.jacl.2024.06.002","article-title":"Association between very high HDL-C levels and mortality: a systematic review and meta-analysis","volume":"18","author":"Mamede","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101672_bib0026","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.M038877","article-title":"Scavenger receptor-BI is a receptor for lipoprotein(a)","volume":"54","author":"Yang","year":"2013","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101672_bib0027","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jacc.2007.10.033","article-title":"The yin and Yang of high-density lipoprotein cholesterol\u204e\u204eeditorials published in the journal of the american college of cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the american college of cardiology","volume":"51","author":"Genest","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101672_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jacl.2007.02.005","article-title":"Effects of lifestyle interventions on high-density lipoprotein cholesterol levels","volume":"1","author":"Roussell","year":"2007","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101672_bib0029","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/nu15051221","article-title":"Excessive consumption of alcoholic beverages and extremely high levels of high-density lipoprotein cholesterol (HALP) in the ELSA-Brasil cohort baseline","volume":"15","author":"Enriquez-Martinez","year":"2023","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101672_bib0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice*","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101672_bib0031","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101672_bib0032","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101672_bib0033","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00002018-200124060-00003","article-title":"Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels","volume":"24","author":"Mantel-Teeuwisse","year":"2001","journal-title":"Drug Saf"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101672_bib0034","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/01.CIR.93.10.1928","article-title":"Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women","volume":"93","author":"Guetta","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101672_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2014.11.008","article-title":"Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis","volume":"37","author":"Sun","year":"2015","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101672_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.RV22044","article-title":"High-sensitivity C-reactive protein and residual inflammatory risk in coronary artery disease: the pathophysiology, prognosis, and emerging therapies","volume":"33","author":"Katamine","year":"2026","journal-title":"J Atheroscler Thromb"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101672_bib0037","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.amjcard.2012.06.056","article-title":"High-density lipoprotein cholesterol, high-sensitivity C-reactive protein, and cardiovascular disease in United States adults","volume":"110","author":"Bilhorn","year":"2012","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101672_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101217","article-title":"Coronary artery calcium for risk stratification among persons with very high HDL cholesterol","volume":"3","author":"Razavi","year":"2024","journal-title":"JACC Adv"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101672_bib0039","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2224","article-title":"Assessment of the role of Niacin in managing cardiovascular disease outcomes: a systematic review and meta-analysis","volume":"2","author":"D\u2019Andrea","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101672_bib0040","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2014.01.426","article-title":"Effects of Niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease","volume":"113","author":"Zambon","year":"2014","journal-title":"Am J Cardiol"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101672_bib0041","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2016.08.007","article-title":"Effect of extended-release niacin on plasma lipoprotein(a) levels: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"65","author":"Sahebkar","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpc.2026.101672_bib0042","article-title":"Probucol: revisiting as a multifaceted therapeutic agent in atherosclerosis","volume":"16","author":"Li","year":"2025","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.ajpc.2026.101672_bib0043","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s11883-024-01231-5","article-title":"Obicetrapib\u2014the rebirth of CETP inhibitors?","volume":"26","author":"Chang","year":"2024","journal-title":"Curr Atheroscler Rep"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726002473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:25:45Z","timestamp":1787689545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726002473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"alternative-id":["S2666667726002473"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101672","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-density lipoprotein cholesterol: function, dysfunction, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101672"}}